Rocket


News + Filings
Transactions



Naesens Janwillem

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
02/22/2022Cyteir Therapeutics, Inc.CYTGrantStock Option (Right to Buy)14.2k$5.96$84.3k 02/22/2022
06/22/2021Cyteir Therapeutics, Inc.CYTConversionCommon Stock3.3M$0.00$0See Footnote06/22/2021
06/22/2021Cyteir Therapeutics, Inc.CYTPurchaseCommon Stock277.8k$18.00$5MSee Footnote06/22/2021
06/22/2021Cyteir Therapeutics, Inc.CYTConversionSeries B Convertible Preferred Stock10M$0.00$0See Footnote06/22/2021
06/22/2021Cyteir Therapeutics, Inc.CYTConversionSeries C Convertible Preferred Stock1.1M$0.00$0See Footnote06/22/2021

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy